CD19 Recombinant Rabbit Monoclonal Antibody [JF100-06]
Usd: 205 Special Discount
Specification
Safety datasheet
Select your chosen country/region
- MSDS_HUABIO.pdf
- MSDS_HUABIO.pdf
- MSDS_ET1702-93_Europe.pdf
- No MSDS Found
Overview
Product Name
CD19 Recombinant Rabbit Monoclonal Antibody [JF100-06]
Antibody Type
Recombinant Rabbit monoclonal Antibody
Immunogen
Recombinant protein within Human CD19 aa 294-556 / 556.
Species Reactivity
Human
Validated Applications
WB, IF-Cell, IF-Tissue, IHC-P, FC, mIHC
Target Molecular Weight
Predicted band size: 61 kDa
Positive Control
Raji cell lysate, Ramos cell lysate, Daudi cell lysate, Raji, human spleen tissue, Daudi, human tonsils tissue.
Conjugation
unconjugated
Clone Number
JF100-06
RRID
Reactivity Data
Verified (internally validated)
Reported in literature (not internally validated)
Predicted reactive (based on sequence homology)
Not recommended (failed internal validation)
| WB | IHC-P | FC | IF-Cell | IF-Tissue | |
|---|---|---|---|---|---|
| human |
|
|
|
|
|
Product Features
Form
Liquid
Concentration
1 mg/mL.(The concentration of this product may be batch-dependent)
Storage Instructions
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). Store at -20℃ long term.
Storage Buffer
1*PBS (pH7.4), 0.1% BSA, 40% Glycerol, 0.2% Proclean 950.
Isotype
IgG
Purification Method
Protein A affinity purified.
Application Dilution
-
WB
-
1:10,000
-
IF-Cell
-
1:50
-
IHC-P
-
1:1,000
-
IF-Tissue
-
1:200
-
FC
-
1:1,000
-
mIHC
-
1:500
Target
Function
B-lymphocyte antigen CD19, also known as CD19 molecule (Cluster of Differentiation 19), B-Lymphocyte Surface Antigen B4, T-Cell Surface Antigen Leu-12 and CVID3 is a transmembrane protein that in humans is encoded by the gene CD19. In humans, CD19 is expressed in all B lineage cells. Contrary to some early doubts, human plasma cells do express CD19, as confirmed by others. CD19 plays two major roles in human B cells: on the one hand, it acts as an adaptor protein to recruit cytoplasmic signaling proteins to the membrane; on the other, it works within the CD19/CD21 complex to decrease the threshold for B cell receptor signaling pathways. Due to its presence on all B cells, it is a biomarker for B lymphocyte development, lymphoma diagnosis and can be utilized as a target for leukemia immunotherapies.
Background References
1. Walls A et al. Characterization of B-Cells in tonsils of patients diagnosed with pediatric autoimmune neuropsychiatric disorder associated streptococcus. Int J Pediatr Otorhinolaryngol 80:49-52 (2016).
2. Shi H et al. Long non-coding RNA expression profile in minor salivary gland of primary Sj gren\'s syndrome. Arthritis Res Ther 18:109 (2016).
Tissue Specificity
Detected on marginal zone and germinal center B cells in lymph nodes. Detected on blood B cells (at protein level).
Post-translational Modification
Phosphorylated on tyrosine following B-cell activation. Phosphorylated on tyrosine residues by LYN. Tyrosine residues are phosphorylated sequentially after activation of the B cell receptor. Phosphorylation of Tyr-531 is extremely rapid, followed by phosphorylation at Tyr-409. In contrast, phosphorylation of Tyr-500 appears more slowly and is more transient, returning rapidly to basal levels (By similarity).
Subcellular Location
Membrane.
UNIPROT
Synonyms
antibody
deficiency due to defect in CD19, included antibody
AW495831 antibody
B lymphocyte antigen CD19 antibody
B lymphocyte surface antigen B4 antibody
B-lymphocyte antigen CD19 antibody
B-lymphocyte surface antigen B4 antibody
B4 antibody
CD19 antibody
CD19 antigen antibody
Expandantibody
deficiency due to defect in CD19, included antibody
AW495831 antibody
B lymphocyte antigen CD19 antibody
B lymphocyte surface antigen B4 antibody
B-lymphocyte antigen CD19 antibody
B-lymphocyte surface antigen B4 antibody
B4 antibody
CD19 antibody
CD19 antigen antibody
CD19 molecule antibody
Cd19 protein antibody
CD19_HUMAN antibody
CVID3 antibody
Differentiation antigen CD19 antibody
Leu 12 antibody
Leu-12 antibody
Leu12 antibody
MGC109570 antibody
MGC12802 antibody
T-cell surface antigen Leu-12 antibody
CollapseImages
-
☑ Relative expression (RE)
Western blot analysis of CD19 on different lysates with Rabbit anti-CD19 antibody (ET1702-93) at 1/10,000 dilution.
Lane 1: Raji cell lysate
Lane 2: Ramos cell lysate
Lane 3: 293T cell lysate (negative)
Lane 4: Daudi cell lysate
Lane 5: K-562 cell lysate (negative)
Lysates/proteins at 20 µg/Lane.
Predicted band size: 61 kDa
Observed band size: 90 kDa
Exposure time: 25 seconds; ECL: K1801;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1702-93) at 1/10,000 dilution was used in primary antibody dilution (K1803) at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature. -
☑ Relative expression (RE)
Immunocytochemistry analysis of Raji (positive) and 293T (negative) labeling CD19 with Rabbit anti-CD19 antibody (ET1702-93) at 1/50 dilution.
Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 15 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-CD19 antibody (ET1702-93) at 1/50 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (HA601187, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
Immunohistochemical analysis of paraffin-embedded human spleen tissue with Rabbit anti-CD19 antibody (ET1702-93) at 1/1,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1702-93) at 1/1,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Flow cytometric analysis of Daudi cells labeling CD19.
Cells were fixed and permeabilized. Then stained with the primary antibody (ET1702-93, 1ug/ml) (red) compared with Rabbit IgG Isotype Control (green). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Rabbit IgG Secondary antibody (HA1121) at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black). -
Flow cytometric analysis of Raji cells labeling CD19.
Cells were fixed and permeabilized. Then stained with the primary antibody (ET1702-93, 1ug/ml) (red) compared with Rabbit IgG Isotype Control (green). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Rabbit IgG Secondary antibody (HA1121) at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black). -
mIHC analysis of human tonsils tissue (Formalin/PFA-fixed paraffin-embedded sections) with Rabbit anti-CD19 antibody (ET1702-93) at 1/500 dilution. The immunostaining was performed with the IRISKitCmTSA Kit (900808). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 30 mins at 95℃. DAPI (blue) was used as a nuclear counter stain. Image acquisition was performed with Olympus VS200 Slide Scanner.
-
Application: IF-Tissue
Species: Human
Site: spleen
Sample: Paraffin-embedded section
Antibody concentration: 1/200
Citation
-
Immunotherapy-induced sialadenitis: sjögren’s syndrome or a new sialadenitis
Journal: Frontiers In Immunology
DOI: 10.3389/fimmu.2026.1755419
IF: 5.9
Application: IHC
Reactivity: Human
Publish date: 2026 Feb
-
A single-cell atlas of liver metastases of colorectal cancer reveals reprogramming of the tumor microenvironment in response to preoperative chemotherapy
Journal: Cell Discovery
DOI:
IF: 10.841
Application: IHC-P
Reactivity: Human
Publish date: 2021 Sept
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Products with the same target and pathway
CD19 Recombinant Rabbit Monoclonal Antibody [JF100-06] - BSA and Azide free
Application: WB,IF-Cell,IF-Tissue,IHC-P,FC
Reactivity: Human
Conjugate: unconjugated
CD19 Recombinant Rabbit Monoclonal Antibody [JF099-9]
Application: WB,FC
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
FITC Conjugated CD19 Recombinant Mouse Monoclonal Antibody [PSH14-97]
Application: FC
Reactivity: Human
Conjugate: FITC
APC Conjugated CD19 Recombinant Rabbit Monoclonal Antibody [PSH13-44]
Application: FC
Reactivity: Human
Conjugate: APC
CD19 Mouse Monoclonal Antibody [A3-A8]
Application: WB,IHC-P,FC
Reactivity: Human,Mouse
Conjugate: unconjugated
CD19 Recombinant Rabbit Monoclonal Antibody [PSH13-44]
Application: WB,IF-Cell,FC
Reactivity: Human
Conjugate: unconjugated
CD19 Recombinant Rabbit Monoclonal Antibody [PSH13-44] - BSA and Azide free
Application: WB,IF-Cell,FC
Reactivity: Human
Conjugate: unconjugated
FITC Conjugated CD19 Recombinant Rabbit Monoclonal Antibody [PSH13-44]
Application: FC
Reactivity: Human
Conjugate: FITC
PE Conjugated CD19 Recombinant Rabbit Monoclonal Antibody [PSH13-44]
Application: FC
Reactivity: Human
Conjugate: PE
CD19 Rabbit Polyclonal Antibody
Application: WB
Reactivity: Human,Mouse
Conjugate: unconjugated
CD19 Recombinant Rabbit Monoclonal Antibody
Application: mIHC
Reactivity: Human
Conjugate: unconjugated